Revenues in USD of Unicycive Therapeutics, Inc. from Q3 2022 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
Summary
Unicycive Therapeutics, Inc. quarterly/annual Revenues history and growth rate from Q3 2022 to 2023.
  • Unicycive Therapeutics, Inc. Revenues for the quarter ending March 31, 2023 was $675K.
  • Unicycive Therapeutics, Inc. annual Revenues for 2023 was $675K, a 29% decline from 2022.
Revenues, Quarterly (USD)
Revenues, Annual (USD)
Revenues, YoY Annual Growth (%)

Unicycive Therapeutics, Inc. Quarterly Revenues (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2023 $675K Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-13
Q3 2022 $951K Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14

Unicycive Therapeutics, Inc. Annual Revenues (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $675K -$276K -29% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-31
2022 $951K Jan 1, 2022 Dec 31, 2022 10-K 2024-03-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.